A patient is presented with reversible clinical and biochemical hepatocellular injury secondary to isoniazid (INH). This apparently rare drug reaction in children is compared with the more common transient hypertransaminasemia induced by isoniazid. A review of the clinical literature and basic pharmacologic mechanisms of isoniazid-induced hepatotoxicity has led to a rational plan for monitoring and managing children who are treated with INH.
No takes yet. Share an insight, caveat, or question.
Stein et al. (1979) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: